Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Structural Basis For Elastolytic Substrate Specificity In Rodent α-Chymases*
J. Kervinen, M. Abad, C. Crysler, M. Kolpak, Andrew D. Mahan, J. Masucci, S. Bayoumy, M. D. Cummings, X. Yao, M. Olson, Lawrence de Garavilla, L. Kuo, I. C. Deckman, J. Spurlino
Published 2008 · Biology
Save to my Library
Download PDFAnalyze on Scholarcy
Divergence of substrate specificity within the context of a common structural framework represents an important mechanism by which new enzyme activity naturally evolves. We present enzymological and x-ray structural data for hamster chymase-2 (HAM2) that provides a detailed explanation for the unusual hydrolytic specificity of this rodent α-chymase. In enzymatic characterization, hamster chymase-1 (HAM1) showed typical chymase proteolytic activity. In contrast, HAM2 exhibited atypical substrate specificity, cleaving on the carboxyl side of the P1 substrate residues Ala and Val, characteristic of elastolytic rather than chymotryptic specificity. The 2.5-Å resolution crystal structure of HAM2 complexed to the peptidyl inhibitor MeOSuc-Ala-Ala-Pro-Ala-chloromethylketone revealed a narrow and shallow S1 substrate binding pocket that accommodated only a small hydrophobic residue (e.g. Ala or Val). The different substrate specificities of HAM2 and HAM1 are explained by changes in four S1 substrate site residues (positions 189, 190, 216, and 226). Of these, Asn189, Val190, and Val216 form an easily identifiable triplet in all known rodent α-chymases that can be used to predict elastolytic specificity for novel chymase-like sequences. Phylogenetic comparison defines guinea pig and rabbit chymases as the closest orthologs to rodent α-chymases.
This paper references
A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters.
Masato Sakaguchi (2004)
A despecialization step underlying evolution of a family of serine proteases.
M. A. Wouters (2003)
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
J. Thompson (1994)
Sheep mast-cell proteinases-1 and -3: cDNA cloning, primary structure and molecular modelling of the enzymes and further studies on substrate specificity.
S. McAleese (1998)
Purification and characterization of angiotensin II-generating chymase from hamster cheek pouch.
S. Takai (1996)
Cloning of the cDNAs for mast-cell chymases from the jejunum of Mongolian gerbils, Meriones unguiculatus, and their sequence similarities with chymases expressed in the connective-tissue mast cells of mice and rats.
H. Itoh (1996)
Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models.
M. Miyazaki (2006)
Expansion of the mast cell chymase locus over the past 200 million years of mammalian evolution
Maike Gallwitz (2006)
Serine protease mechanism and specificity.
L. Hedstrom (2002)
Mast cell tryptases and chymases in inflammation and host defense
G. Caughey (2007)
 Processing of X-ray diffraction data collected in oscillation mode.
Z. Otwinowski (1997)
The Chymase, Mouse Mast Cell Protease 4, Constitutes the Major Chymotrypsin-like Activity in Peritoneum and Ear Tissue. A Role for Mouse Mast Cell Protease 4 in Thrombin Regulation and Fibronectin Turnover
E. Tchougounova (2003)
Isolation of chymase complexed with physiological inhibitor similar to secretory leukocyte protease inhibitor (SLPI) from hamster cheek pouch tissues.
K. Takao (2001)
Mast cells: multipotent local effector cells in atherothrombosis
P. Kovanen (2007)
The role of the mast cell in the pathophysiology of asthma.
P. Bradding (2006)
Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase.
M. N. Greco (2007)
The influence of residue 190 in the S1 site of trypsin‐like serine proteases on substrate selectivity is universally conserved
K. Sichler (2002)
GeneWise and Genomewise.
E. Birney (2004)
Rapid lineage-specific diversification of the mast cell chymase locus during mammalian evolution
Maike Gallwitz (2006)
Crystallography & NMR system: A new software suite for macromolecular structure determination.
A. Brünger (1998)
Sequence determinants of function and evolution in serine proteases.
M. Krem (2000)
Angiotensin II-Forming Activity in a Reconstructed Ancestral Chymase
U. Chandrasekharan (1996)
Proteolytic Enzymes (Barrett
N. D. Rawlings (2004)
Molecular cloning of the mouse mast cell protease-5 gene. A novel secretory granule protease expressed early in the differentiation of serosal mast cells.
H. McNeil (1991)
Angiotensin II generation by mast cell α- and β-chymases
G. Caughey (2000)
Cloning of the gene and cDNA for hamster chymase 2, and expression of chymase 1, chymase 2 and angiotensin-converting enzyme in the terminal stage of cardiomyopathic hearts.
N. Shiota (1998)
Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 A resolution.
D. Wang (1985)
Recombinant Expression of Human Mast Cell Proteases Chymase and Tryptase
Z. Wang (1998)
Mechanism‐based isocoumarin inhibitors for serine proteases: Use of active site structure and substrate specificity in inhibitor design
J. Powers (1989)
Converting trypsin to chymotrypsin: the role of surface loops.
L. Hedstrom (1992)
The guinea-pig is not a rodent
A. D’Erchia (1996)
Mast cells and inflammatory kidney disease
U. Blank (2007)
New developments in the genetics and activation of mast cell proteases.
G. Caughey (2002)
Extended Substrate Specificity of Rat Mast Cell Protease 5, a Rodent α-Chymase with Elastase-like Primary Specificity*
U. Karlson (2003)
Cardiac remodeling and angiotensin II-forming enzyme activity of the left ventricle in hamsters with chronic pressure overload induced by ascending aortic stenosis.
M. Shimizu (2006)
Neutrophil serine proteases: specific regulators of inflammation
C. Pham (2006)
Evolutionary Divergence of Substrate Specificity within the Chymotrypsin-like Serine Protease Fold*
J. Perona (1997)
The Jalview Java alignment editor
M. Clamp (2004)
Activation of angiotensin II‐forming chymase in the cardiomyopathic hamster heart
N. Shiota (1997)
Suppression of basic fibroblast growth factor‐induced angiogenesis by a specific chymase inhibitor, BCEAB, through the chymase‐angiotensin‐dependent pathway in hamster sponge granulomas
Michiko Muramatsu (2002)
Granzyme-like sequences in bony fish shed light on the emergence of hematopoietic serine proteases during vertebrate evolution.
S. Wernersson (2006)
PHENIX: building new software for automated crystallographic structure determination.
P. Adams (2002)
Handbook of proteolytic enzymes
A. Barrett (1998)
The 1.8 A crystal structure of human cathepsin G in complex with Suc‐Val‐Pro‐PheP‐(OPh)2: a Janus‐faced proteinase with two opposite specificities.
P. Hof (1996)
Rodent α‐chymases are elastase‐like proteases
Y. Kunori (2002)
Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease.
A. Andoh (2006)
A Novel, Potent Dual Inhibitor of the Leukocyte Proteases Cathepsin G and Chymase
L. de Garavilla (2005)
Evidence for diversity of substrate specificity among members of the chymase family of serine proteases
S. Solivan (2002)
Rodent Elastolytic -Chymases 436 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME
C. T. Pham (2006)
On the size of the active site in proteases. I. Papain.
I. Schechter (1967)
Chymase is activated in the pulmonary inflammation and fibrosis induced by paraquat in hamsters.
K. Orito (2004)
Cloning of the cDNA encoding a novel rat mast-cell proteinase, rMCP-3, and its expression in comparison with other rat mast-cell proteinases.
H. Ide (1995)
This paper is referenced by
Extended cleavage specificities of mast cell proteases 1 and 2 from golden hamster: Classical chymase and an elastolytic protease comparable to rat and mouse MCP-5
M. Thorpe (2018)
Cleavage Specificity of Mast Cell Chymases
M. Andersson (2008)
Granule Associated Serine Proteases of Hematopoietic Cells – An Analysis of Their Appearance and Diversification during Vertebrate Evolution
Srinivas Akula (2015)
Mast cell peptidases: chameleons of innate immunity and host defense.
N. Trivedi (2010)
Granule proteases of hematopoietic cells, a family of versatile inflammatory mediators - an update on their cleavage specificity, in vivo substrates, and evolution.
L. Hellman (2014)
Extended Cleavage Specificities of Rabbit and Guinea Pig Mast Cell Chymases: Two Highly Specific Leu-Ases
Yuan Zhongwei (2019)
Extended Cleavage Specificities of Two Mast Cell Chymase-Related Proteases and One Granzyme B-Like Protease from the Platypus, a Monotreme
Zhirong Fu (2020)
Extended cleavage specificity of human neutrophil cathepsin G: A low activity protease with dual chymase and tryptase-type specificities
M. Thorpe (2018)
Guinea Pig Chymase Is Leucine-specific
G. Caughey (2008)
Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents.
Chih-Chang Wei (2010)
Mast cell proteases as pharmacological targets.
G. Caughey (2016)
How Immune Peptidases Change Specificity: Cathepsin G Gained Tryptic Function but Lost Efficiency during Primate Evolution
W. Raymond (2010)
The extended substrate specificity of the human mast cell chymase reveals a serine protease with well-defined substrate recognition profile.
M. Andersson (2009)
during Primate Evolution Tryptic Function but Lost Efficiency Specificity: Cathepsin G Gained How Immune Peptidases Change
C. Craik (2010)
Hematopoietic Serine Proteases from the Mast Cell Chymase and Tryptase Loci - a Functional and Evolutionary Analysis
J. Reimer (2008)
Extended cleavage specificity of sheep mast cell protease‐2: A classical chymase with preference to aromatic P1 substrate residues
Zhirong Fu (2019)
Potency variation of small-molecule chymase inhibitors across species.
J. Kervinen (2010)
Chapter 590 – Chymases
G. Caughey (2013)